Takumi Maruhashi, Daisuke Sugiura, Il-mi Okazaki, Kenji Shimizu, Takeo K. Maeda, Jun Ikubo, Harunori Yoshikawa, Katsumi Maenaka, Naozumi Ishimaru, Hidetaka Kosako, et al. Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity. Immunity. 2022
Daisuke Sugiura, Il-Mi Okazaki, Takeo K Maeda, Takumi Maruhashi, Kenji Shimizu, Rieko Arakaki, Tatsuya Takemoto, Naozumi Ishimaru, Taku Okazaki. PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity. Nature immunology. 2022. 23. 3. 399-410
Daisuke Sugiura, Kenji Shimizu, Takumi Maruhashi, Il-Mi Okazaki, Taku Okazaki. T cell-intrinsic and -extrinsic regulation of PD-1 function. International immunology. 2021. 33. 12. 693-698
Kenji Shimizu, Daisuke Sugiura, Il-mi Okazaki, Takumi Maruhashi, Tatsuya Takemoto, Taku Okazaki. PD-1 preferentially inhibits the activation of low-affinity T cells. Proceedings of the National Academy of Sciences. 2021. 118. 35. e2107141118-e2107141118
Takumi Maruhashi, Daisuke Sugiura, Il-mi Okazaki, Taku Okazaki. LAG-3: from molecular functions to clinical applications. Journal for ImmunoTherapy of Cancer. 2020. 8. 2. e001014-e001014
